MP81-09 NOVEL LNCAMPC STIMULATED LIF/LIFR PATHWAY PROMOTES METASTASIS AND SERVES AS THERAPEUTIC TARGET IN PROSTATE CANCER

Wei Zhang,Xiaolei Shi,Rui Chen,Shancheng Ren,Yinghao Sun
DOI: https://doi.org/10.1097/01.ju.0000557428.10701.e1
2019-01-01
Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology III (MP81)1 Apr 2019MP81-09 NOVEL LNCAMPC STIMULATED LIF/LIFR PATHWAY PROMOTES METASTASIS AND SERVES AS THERAPEUTIC TARGET IN PROSTATE CANCER Wei Zhang*, Xiaolei Shi, Rui Chen, Shancheng Ren, and Yinghao Sun Wei Zhang*Wei Zhang* More articles by this author , Xiaolei ShiXiaolei Shi More articles by this author , Rui ChenRui Chen More articles by this author , Shancheng RenShancheng Ren More articles by this author , and Yinghao SunYinghao Sun More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000557428.10701.e1AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail WITHDRAWN Shanghai, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e1174-e1175 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Wei Zhang* More articles by this author Xiaolei Shi More articles by this author Rui Chen More articles by this author Shancheng Ren More articles by this author Yinghao Sun More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?